Lucinda Stebbins - Tekla Life Insider

XHQLX -- USA Fund  

USD 20.98  0.03  0.14%

  Executive
Ms. Lucinda H. Stebbins, CPA is Independent Trustee of HQ Life Sciences Investors. Ms. Stebbins brings to each Fund over twenty years experience working in the fund industry, providing valuable perspectives on a variety of technical and industry matters. She serves as Chairman of the Audit Committee and serves on the Governance and Nominating Committee of each Fund. She started her career with the investment management firm of Scudder, Stevens and Clark, which was later merged into the U.S. operations of Zurich Financial Services, and then finally acquired by Deutsche Bank. She served as a Senior Vice President at Scudder Investments and subsequently as a Director at Deutsche Asset Management and was an officer of approximately 200 funds in these complexes
Age: 71  Executive Since 2006  CPA    
Stebbins' expertise is in the accounting, tax, and regulatory sides of the fund business, and she continues to act as an independent consultant to the fund industry. Prior to joining Scudder, she was a Senior Manager at Price Waterhouse and is a member of the Massachusetts Society of CPAs. She also serves on the Board of Solstice Home Care, Inc., served on the Board of Bald Peak Land Company and was on a number of nonprofit Boards. She holds an MBA degree from Babson College and a BA in economics from Wellesley College.

Management Performance (%)

Similar Money Managers

Found 11 records

One Year Return

Rick RiederBlackRock Strategic Income Opps
0.0%
Daniel ShackelfordT Rowe Price New Income R
5.57%
Carl EichstaedtWestern Asset Core Plus Bond I
7.65%
Barbara MillerJPMorgan Core Bond I
8.05%
Carl EichstaedtWestern Asset Core Plus Bond FI
6.37%
Bob MillerBlackRock Strategic Income Opps
0.0%
Dina PerryAmerican Funds Fundamental Invs
-1.05%
James LovelaceAmerican Funds Capital Income B
3.44%
Andrew OBrienLord Abbett Short Duration Inco
0.0%
Mark DenningAmerican Funds SMALLCAP World R
-5.55%
Barbara MillerJPMorgan Core Bond R4
0.0%

Fund Summary

The fund is listed under null category and is part of null family.

Tekla Life Sciences Leadership Team

William Reardon, Independent Trustee
Michael Bonney, Independent Trustee
Oleg Pohotsky, Independent Trustee
Lucinda Stebbins, Independent Trustee
Daniel Omstead, President Trustee
Uwe Reinhardt, Independent Trustee
Rakesh Jain, Independent Trustee

Fund Performance Indicators

Current Sentiment - XHQLX

Tekla Life Sciences Investor Sentiment
Macroaxis portfolio users are unemotional in their outlook on investing in Tekla Life Sciences Investors. What is your outlook on investing in Tekla Life Sciences Investors? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Also Currentnly Active

Purchased over 20 shares of
few hours ago
Traded for 106.27
Purchased over 200 shares of
few hours ago
Traded for 10.56
Purchased over 70 shares of
few hours ago
Traded for 39.4
See also Your Current Watchlist. Please also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">